Michael Ackermann - 05 Aug 2021 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
Director
Signature
/s/ Leonard M. Greenstein, Attorney-in-Fact
Issuer symbol
TARS
Transactions as of
05 Aug 2021
Net transactions value
-$34,576
Form type
4
Filing time
06 Aug 2021, 16:16:03 UTC
Previous filing
17 Jun 2021
Next filing
10 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARS Common Stock Sale $29,575 -1,183 -0.1% $25.00 1,231,998 05 Aug 2021 Direct F1
transaction TARS Common Stock Sale $2,500 -100 -0.01% $25.00 1,231,898 05 Aug 2021 Direct F1
transaction TARS Common Stock Sale $2,501 -100 -0.01% $25.01 1,231,798 05 Aug 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2021.